Physician profile
Rajeev Marreddy
NPI 1346551769
$5,789.51
in general payments reported to CMS, 2019-2025
26 companies · $629 in 2025
The $629 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $1,619 · 2021: $590 · 2022: $381 · 2023: $1,191 · 2024: $814 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,038.53 | 2019-2024 | Mitraclip, Aveir, Diamondback Peripheral |
| Boston Scientific Corporation | $1,103.13 | 2019-2025 | Avvigo Guidance System, Ranger, Comet |
| Inari Medical, INC. | $620.15 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Avinger INC. | $479.16 | 2019-2023 | Pantheris |
| Penumbra, INC. | $338.94 | 2023-2025 | Indigo System, Penumbra System |
| Abiomed | $270.19 | 2021-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $192.75 | 2019-2021 | |
| Shockwave Medical, INC | $165.30 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $76.03 | 2020-2022 | |
| Atricure, INC. | $63.51 | 2025 | Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.90 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $54.47 | 2020-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $44.46 | 2021-2022 | |
| Scpharmaceuticals INC. | $43.41 | 2025 | |
| Cordis US Corp. | $33.48 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $29.89 | 2021 | |
| Pfizer INC. | $29.27 | 2020-2022 | |
| Medtronic Vascular, INC. | $23.29 | 2019 | |
| Medtronic, INC. | $22.15 | 2025 | In.Pact Admiral |
| Chiesi USA, INC. | $20.73 | 2023 | Kengreal |
| Philips North America LLC | $17.28 | 2025 | Igt Devices Systems Undivided |
| Teleflex LLC | $16.55 | 2025 | Guideliner |
| Amgen INC. | $14.68 | 2024 | |
| Terumo Medical Corporation | $13.02 | 2019 | |
| Cardinal Health 200 LLC | $13.01 | 2020 | |
| Cardiovascular Systems INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Marreddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.